Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities YMAB - Y-mAbs Therapeutics, Inc.
4.31 M
LAST VALUE
616.39%
2 YEAR CAGR
-49.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR